NOVO-CHOLAMINE - PWR 4G/DOSE 4 G
CHOLESTYRAMINE RESIN : 4 G · DIN 02139189 · NOVOPHARM LIMITED
Health Canada status: CANCELLED POST MARKET
What is NOVO-CHOLAMINE - PWR 4G/DOSE?
NOVO-CHOLAMINE - PWR 4G/DOSE 4 G contains CHOLESTYRAMINE RESIN : 4 G. It is listed in the Health Canada Drug Product Database under DIN 02139189, held by NOVOPHARM LIMITED, supplied as POWDER ; SUSPENSION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Oct-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is NOVO-CHOLAMINE - PWR 4G/DOSE called?
The same molecule, COLESTYRAMINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Questran Lite | Latin | Australia |
| QUESTRAN POWDER | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02139189 |
|---|---|
| Brand name | NOVO-CHOLAMINE - PWR 4G/DOSE |
| Generic / active ingredient | CHOLESTYRAMINE RESIN : 4 G |
| Manufacturer | NOVOPHARM LIMITED |
| Strength | 4 G |
| Dosage form | POWDER ; SUSPENSION |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C10AC01 COLESTYRAMINE |
| AHFS class | 24:06.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Oct-2015 |
| Original market date | 1995-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02139189 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2139189 |
| Brand name | NOVO-CHOLAMINE - PWR 4G/DOSE |
| Active ingredient / INN | CHOLESTYRAMINE RESIN : 4 G |
| ATC code | C10AC01 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C10 |
| AHFS class | 24:06.04 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | NOVOPHARM LIMITED |
Which pack is which?
| Strength on the label | 4 G |
|---|---|
| Dosage form | POWDER ; SUSPENSION |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code C10AC01 COLESTYRAMINE. 3 of 23 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CHOLESTYRAMINE-ODAN | 4 G | Powder | ODAN LABORATORIES LTD | MARKETED | DIN 02455609 |
| JAMP-CHOLESTYRAMINE | 4 G | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | MARKETED | DIN 02478595 |
| OLESTYR | 4 G | POWDER FOR SUSPENSION | PHARMASCIENCE INC | MARKETED | DIN 02210320 |
| ALTI-CHOLESTYRAMINE LIGHT | 4 G | POWDER ; PACKAGE | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02054825 |
| CHOLESTYRAMINE | 4 G / 5 G | POWDER FOR SUSPENSION | SORRES PHARMA INC | CANCELLED POST MARKET | DIN 02236969 |
| CHOLESTYRAMINE | 4 G / 9 G | POWDER FOR SUSPENSION | SORRES PHARMA INC | CANCELLED POST MARKET | DIN 02236970 |
| JAMP-CHOLESTYRAMINE | 4 G | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | APPROVED | DIN 02494531 |
| NOVO-CHOLAMINE LIGHT - PWR 4G/DOSE | 4 G | SUSPENSION ; POWDER | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02139197 |
| OLESTYR | 4 G | POWDER FOR SUSPENSION | PHARMASCIENCE INC | DORMANT | DIN 00890960 |
| PHL-CHOLESTYRAMINE LIGHT - 210G TIN | 4 G / 5 G | POWDER FOR SUSPENSION | PHARMEL INC | CANCELLED POST MARKET | DIN 02237132 |
Who else supplies COLESTYRAMINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COLESTYRAMINE appears in 17 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does COLESTYRAMINE cost around the world?
COLESTYRAMINE is listed on 2 national price registers Nexara tracks, across 3 pack listings published on 2 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Australia | ex-manufacturer | 1 | 2 | 08 Sep 2026 |
| Saudi Arabia | public | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.